November 10-15

The official news source of

ACR Convergence 2023

San Diego, CA

  • New ACR vaccination guideline in press

    New ACR vaccination guideline in press

    With the recognition that rheumatic and musculoskeletal diseases (RMDs) and immunosuppression can affect the immunogenicity and safety of vaccines, the ACR has issued its own guideline for vaccination in patients with RMDs. Project leader Anne Bass, MD, and other panelists outlined the new recommendations at ACR Convergence.

  • Plenary II details data on biosimilar switching, co-pays, and other new research

    Plenary II details data on biosimilar switching, co-pays, and other new research

    The second of three plenary sessions addressed ground-breaking developments in rheumatic diseases, including Sjögren’s syndrome, systemic sclerosis, lupus, and osteoarthritis. Raisa Lomanto Silva, MD, discussed drug co-pay costs and adherence.

  • Rheumatologists can help young patients to preserve their reproductive health

    Rheumatologists can help young patients to preserve their reproductive health

    Children with rheumatic disease often become adults with rheumatic disease. Cuoghi Edens, MD, FAAP, and Jacqueline Maher, MD, discussed how rheumatology providers can support reproductive health and protect fertility in adolescent patients.

  • Experts offer guidance on contraception safety, legal risks in reproductive health session

    Experts offer guidance on contraception safety, legal risks in reproductive health session

    Panelists including Megan Clowse, MD, MPH, offered practical guidance and tools for discussing contraception and family planning with rheumatology patients. She encouraged honest, accurate conversation, as well as creating an environment of trust and safety.

  • Open communication facilitates dignity and respect in care of gender-diverse patients

    Open communication facilitates dignity and respect in care of gender-diverse patients

    Many transgender and non-binary patients avoid seeking care because of the discrimination they have faced in the clinic. This lack of care can lead to chronic health issues, said Nathan Levitt, FNP-BC, MSN, RN, BSN, MA, in a session on strategies for improving the clinical experience for this population.

  • Experts debate the role of DMARDs in subclinical RA

    Experts debate the role of DMARDs in subclinical RA

    During this year’s Great Debate, experts including Janet Pope, MD, MPH, FRCPC, and Hani El-Gabalawy, MD, FRCPC, reviewed the data on subclinical disease and the risk of progression to rheumatoid arthritis, presenting arguments for and against starting a DMARD in this challenging clinical scenario.